Gossamer Bio Adds $276M in Second Biotech ?Unicorn? IPO of 2019

Gossamer Bio, the San Diego-based biotech founded by former Receptos executives, has raised $276 million in its initial public offering, a total that puts it in a rare class among biotechs that have gone public in recent years. The amount raised surpassed expectations. During the partial federal government shutdown in January, Gossamer announced it would [?]